Chirasmita Nayak Selected Research

dihydroactinidiolide

12/2018

Dihydroactinidiolide, a natural product against Aβ25-35 induced toxicity in Neuro2a cells: Synthesis, in silico and in vitro studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chirasmita Nayak Research Topics

Disease

2	Neoplasms (Cancer) 01/2021 - 12/2018
1	Tuberous Sclerosis (Bourneville's Disease) 07/2022
1	Glioma (Gliomas) 01/2021
1	Infections 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 12/2018

Drug/Important Bio-Agent (IBA)

1	trans-sodium crocetinate (crocetin)IBA 07/2022
1	TOR Serine-Threonine KinasesIBA 07/2022
1	Hormones (Hormone)IBA 07/2022
1	Androgen Receptors (Androgen Receptor)IBA 07/2022
1	Estrogen ReceptorsIBA 07/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2022
1	Biological ProductsIBA 01/2021
1	Transcription Factor 4IBA 01/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	SolventsIBA 12/2018
1	dihydroactinidiolideIBA 12/2018
1	Pharmaceutical PreparationsIBA 12/2018
1	Free RadicalsIBA 12/2018

Therapy/Procedure

1	Highly Active Antiretroviral Therapy (HAART) 01/2019